| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
|
Editorial Policies
Errata The author will be assessed page charge(s) for errata
that result from author error. The journal will cover the costs of
errata that are a result of the editing process. Misconduct If there is a suspicion or allegation of misconduct directed toward any author, The FASEB Journal reserves the right to forward relevant material to the appropriate authorities at the author's institution for investigation. The FASEB Journal recognizes its responsibility to ensure that the suspicion of misconduct has been addressed, but the journal does not make such determinations. The Editor-in-Chief is responsible for the specific editorial conduct of The FASEB Journal and compliance with the relevant policies and procedures. When a report of suspected misconduct has been sent to the Editor-in-Chief, the following course of action will be taken. If the manuscript has yet to be published, all work on the manuscript will stop. No immediate action to already-published material (such as retracting an online pre-print article) will be taken until the matter is resolved. In cases of minor issues, the Editor-in-Chief will contact the corresponding author directly. In cases of major issues, the Editor-in-Chief will inform the Publications Communications Committee (PCC) Chair of the accusation through the Director of Publication by supplying copies of 1) the relevant material and 2) a draft letter to the corresponding author asking for an explanation in a nonjudgmental manner. In some cases, the Editor-in-Chief may contact all of the authors listed on the manuscript. Should the corresponding author’s response fail to resolve the situation satisfactorily, the Editor-in-Chief will contact all of the institutions of the contributing authors. The institutions should then make an inquiry and report back to the Editor-in-Chief. Until the matter is clarified, no papers by any authors on the disputed manuscript will be considered for publication. If scientific misconduct is confirmed by institutional review, the Editor-in-Chief will report this to the PCC Chair and the FASEB Executive Director. Appropriate action will be decided in consultation with the FASEB Office of Publications. Violations considered severe may warrant official withdrawal of a published article or rapid rejection of a manuscript at any stage before publication. If the infraction is less severe, the Editor-in-Chief will send the corresponding author a letter of reprimand reviewed by the PCC Chair. If FASEB has violated the copyright of another journal, the PCC Chair will write a letter of apology to the other journal’s Editor-in-Chief. If no scientific misconduct is found, the manuscript (if unpublished) will be scheduled for publication. For errors in a published article not deemed to be misconduct, an Erratum or Letter to the Editor will be published. If there is a disagreement about the results of the investigation, the Editor-in-Chief reserves the right to restrict the author(s) from publishing in the journal for a specified period of time. Embargo
Policy We ask that authors refrain from publishing large quotes, substantial analysis, or reprinting figures, tables, or other data until the publication/posting date. Authors are welcome to present more detailed information at professional conferences, but authors should refrain from giving out overheads or other handouts that contain substantial material from your article before your publication/posting date. For the embargo date and time for a specific article, please contact cmooneyhan{at}faseb.org or phone (301) 634-7104. Press
Access Credentialed members of the press may request free online access to the journal. For further details, please contact cmooneyhan{at}faseb.org or phone (301) 634-7104. Peer
Review Process Including Rebuttal Policy Manuscripts requested after the IQ stage are reviewed critically. After receipt of a manuscript by the Editor-in-Chief, it is sent to an Associate Editor who sends the manuscript to an appropriate number of reviewers (usually two, depending on the type of manuscript). Editors may ask for suggested reviewer names from an Editorial Board Member. Comments from reviewers are examined by the Editor-in-Chief and/or Associate Editors, who make the final decisions. Rebuttals should be addressed to the Editor-in-Chief at journals@faseb.org. All reviewers remain unknown to the authors. Every manuscript is treated by the Editors and reviewers as privileged information, and they are instructed to exclude themselves from review of any manuscript that might involve a conflict of interest or the appearance thereof. Upon submission of a manuscript, authors must suggest five potential reviewers who have not seen the manuscript before submission. Authors may request disqualification of up to four potential reviewers. Only those individuals who would represent a direct conflict of interest should be excluded. Authors cannot make an extensive or blanket disqualification of a group of possible reviewers, e.g., all potential competitors in one or more industrial laboratories or academic departments. Requests to disqualify reviewers will be honored at the discretion of the Editor assigned to the manuscript. Conflict
of Interest Disclosure Send disclosures to journals@faseb.org. Please make sure the disclosure includes the number of your manuscript. Criteria
for Authorship Procedures
for Changes in Authorship after Acceptance Statement
on the Ethical Use of Humans and/or Animals in Research Access
to Unique Materials such as Cell Lines, Organisms, and Software The FASEB Journal also does not distinguish between microarray data and other sorts of data (proteomics, sequence data, organic syntheses, crystal structures, etc.) All methods must be publicly available and described. Anything published in The FASEB Journal must have all data available not only for review but to every reader, electronic or print. Copyright
and Permissions Policy Copyright Clearance Center, Inc. Upon publication of their manuscript, authors may request a pdf file of their article. Authors may not post this article to the Internet. However, authors may link to their article on The FASEB Journal's Web site. The Journal grants the Author permission to provide a copy of the accepted manuscript to NIH upon acceptance for Journal publication, with public release in PubMed Central twelve months after final print publication by the Journal. Open Access
Option for Authors NIH
Public Access Policy If you choose to submit your accepted manuscript to PMC, you will be asked to indicate when that manuscript should be made available to the public. As copyright holder of your article, the Federation of American Societies for Experimental Biology (FASEB) has the sole right to publish or disseminate it. FASEB, however, grants authors one-time permission to allow public release of their manuscript through PMC 12 months after publication in The FASEB Journal. This period of time is consistent with our existing policy to make all content publicly available through HighWire Press 12 months after print publication. NIH will be able to determine when 12 months have elapsed because FASEB sends NIH electronic feeds of the article metadata upon publication in the journal. You can, therefore, submit your accepted manuscript to PMC at the time of acceptance and will not have to calculate or track time elapsed from publication. Participation in the NIH policy is voluntary and, according to NIH officials, there will be no sanctions of any kind against authors who do not submit their manuscripts. If you have any questions with respect to the NIH Public Access Policy and the publication of your article in The FASEB Journal, please contact Jennifer Pesanelli at jpesanelli@faseb.org. |
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |